Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ronran,

The shares will remain held as treasury stock.  Any of the shares bought back over the last year and held in treasury could have been used/re-issued to pay Fish, but since he is getting cash now instead, we keep the shares, I do believe (for perhaps greater use down the road when they are worth much more, i.e. acquisition).

Share
New Message
Please login to post a reply